Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: Two sides of the same coin

P. Alberti; E. Rossi; D. R. Cornblath; I. S.J. Merkies; T. J. Postma; B. Frigeni; J. Bruna; R. Velasco; A. A. Argyriou; H. P. Kalofonos; D. Psimaras; D. Ricard; A. Pace; E. Galiè; C. Briani; C. Dalla Torre; C. G. Faber; R. I. Lalisang; W. Boogerd; D. Brandsma; S. Koeppen; J. Hense; D. Storey; S. Kerrigan; A. Schenone; S. Fabbri; M. G. Valsecchi; G. Cavaletti

doi:10.1093/annonc/mdt409

Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: Two sides of the same coin

P. Alberti, E. Rossi, D. R. Cornblath, I. S.J. Merkies, T. J. Postma, B. Frigeni, J. Bruna, R. Velasco, A. A. Argyriou, H. P. Kalofonos, D. Psimaras, D. Ricard, A. Pace, E. Galiè, C. Briani, C. Dalla Torre, C. G. Faber, R. I. Lalisang, W. Boogerd, D. BrandsmaS. Koeppen, J. Hense, D. Storey, S. Kerrigan, A. Schenone, S. Fabbri, M. G. Valsecchi, G. Cavaletti

School of Medicine

Research output: Contribution to journal › Article › peer-review

95 Scopus citations

Abstract

Background: The different perception and assessment of chemotherapy-induced peripheral neurotoxicity (CIPN) between healthcare providers and patients has not yet been fully addressed, although these two approaches might eventually lead to inconsistent, possibly conflicting interpretation, especially regarding sensory impairment. Patients and methods: A cohort of 281 subjects with stable CIPN was evaluated with the National Cancer Institute- Common Toxicity Criteria (NCI-CTC v. 2.0) sensory scale, the clinical Total Neuropathy Score (TNSc

Original language	English (US)
Pages (from-to)	257-264
Number of pages	8
Journal	Annals of Oncology
Volume	25
Issue number	1
DOIs	https://doi.org/10.1093/annonc/mdt409
State	Published - Jan 2014

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1093/annonc/mdt409

Cite this

Alberti, P., Rossi, E., Cornblath, D. R., Merkies, I. S. J., Postma, T. J., Frigeni, B., Bruna, J., Velasco, R., Argyriou, A. A., Kalofonos, H. P., Psimaras, D., Ricard, D., Pace, A., Galiè, E., Briani, C., Dalla Torre, C., Faber, C. G., Lalisang, R. I., Boogerd, W., ... Cavaletti, G. (2014). Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: Two sides of the same coin. Annals of Oncology, 25(1), 257-264. https://doi.org/10.1093/annonc/mdt409

Alberti, P, Rossi, E, Cornblath, DR, Merkies, ISJ, Postma, TJ, Frigeni, B, Bruna, J, Velasco, R, Argyriou, AA, Kalofonos, HP, Psimaras, D, Ricard, D, Pace, A, Galiè, E, Briani, C, Dalla Torre, C, Faber, CG, Lalisang, RI, Boogerd, W, Brandsma, D, Koeppen, S, Hense, J, Storey, D, Kerrigan, S, Schenone, A, Fabbri, S, Valsecchi, MG & Cavaletti, G 2014, 'Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: Two sides of the same coin', Annals of Oncology, vol. 25, no. 1, pp. 257-264. https://doi.org/10.1093/annonc/mdt409

@article{63a26305425748099e5988d273dac435,

title = "Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: Two sides of the same coin",

abstract = "Background: The different perception and assessment of chemotherapy-induced peripheral neurotoxicity (CIPN) between healthcare providers and patients has not yet been fully addressed, although these two approaches might eventually lead to inconsistent, possibly conflicting interpretation, especially regarding sensory impairment. Patients and methods: A cohort of 281 subjects with stable CIPN was evaluated with the National Cancer Institute- Common Toxicity Criteria (NCI-CTC v. 2.0) sensory scale, the clinical Total Neuropathy Score (TNSc",

author = "P. Alberti and E. Rossi and Cornblath, {D. R.} and Merkies, {I. S.J.} and Postma, {T. J.} and B. Frigeni and J. Bruna and R. Velasco and Argyriou, {A. A.} and Kalofonos, {H. P.} and D. Psimaras and D. Ricard and A. Pace and E. Gali{\`e} and C. Briani and {Dalla Torre}, C. and Faber, {C. G.} and Lalisang, {R. I.} and W. Boogerd and D. Brandsma and S. Koeppen and J. Hense and D. Storey and S. Kerrigan and A. Schenone and S. Fabbri and Valsecchi, {M. G.} and G. Cavaletti",

year = "2014",

month = jan,

doi = "10.1093/annonc/mdt409",

language = "English (US)",

volume = "25",

pages = "257--264",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

number = "1",

}

TY - JOUR

T1 - Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity

T2 - Two sides of the same coin

AU - Alberti, P.

AU - Rossi, E.

AU - Cornblath, D. R.

AU - Merkies, I. S.J.

AU - Postma, T. J.

AU - Frigeni, B.

AU - Bruna, J.

AU - Velasco, R.

AU - Argyriou, A. A.

AU - Kalofonos, H. P.

AU - Psimaras, D.

AU - Ricard, D.

AU - Pace, A.

AU - Galiè, E.

AU - Briani, C.

AU - Dalla Torre, C.

AU - Faber, C. G.

AU - Lalisang, R. I.

AU - Boogerd, W.

AU - Brandsma, D.

AU - Koeppen, S.

AU - Hense, J.

AU - Storey, D.

AU - Kerrigan, S.

AU - Schenone, A.

AU - Fabbri, S.

AU - Valsecchi, M. G.

AU - Cavaletti, G.

PY - 2014/1

Y1 - 2014/1

N2 - Background: The different perception and assessment of chemotherapy-induced peripheral neurotoxicity (CIPN) between healthcare providers and patients has not yet been fully addressed, although these two approaches might eventually lead to inconsistent, possibly conflicting interpretation, especially regarding sensory impairment. Patients and methods: A cohort of 281 subjects with stable CIPN was evaluated with the National Cancer Institute- Common Toxicity Criteria (NCI-CTC v. 2.0) sensory scale, the clinical Total Neuropathy Score (TNSc

AB - Background: The different perception and assessment of chemotherapy-induced peripheral neurotoxicity (CIPN) between healthcare providers and patients has not yet been fully addressed, although these two approaches might eventually lead to inconsistent, possibly conflicting interpretation, especially regarding sensory impairment. Patients and methods: A cohort of 281 subjects with stable CIPN was evaluated with the National Cancer Institute- Common Toxicity Criteria (NCI-CTC v. 2.0) sensory scale, the clinical Total Neuropathy Score (TNSc

UR - http://www.scopus.com/inward/record.url?scp=84894342495&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84894342495&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdt409

DO - 10.1093/annonc/mdt409

M3 - Article

C2 - 24256846

AN - SCOPUS:84894342495

SN - 0923-7534

VL - 25

SP - 257

EP - 264

JO - Annals of Oncology

JF - Annals of Oncology

IS - 1

ER -

Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: Two sides of the same coin

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this